MTOR and acute myeloid leukemia: Ciclopirox, an antifungal agent, significantly enhances the efficacy of the antileukemia compound PTL against AML in the Kasumi-1 cell line by inhibiting mTOR, showing greater toxicity in combination than either agent alone (Sen et al., 2013).